[Retracted] Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Table 2

Comparison of disease control rates between the two groups (cases, %).

Group	CR	PR	DC	DP	Disease control rate
Observation group (n = 53)	25 (47.17)	17 (32.08)	7 (13.21)	4 (7.55)	92.45
Control group (n = 33)	10 (30.30)	12 (36.36)	4 (12.12)	7 (21.21)	78.79
χ ^2	—	18.736
	—	<0.001